Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

FBIOX vs. PBE: which is better?

Bottom line

FBIOX vs PBE: the short answer

FBIOX (Biotechnology Portfolio) and PBE (Invesco Biotechnology & Genome ETF) are both mutual funds.

But FBIOX is far broader, holding 215 positions to 33 for PBE, so beyond the top names it adds exposure PBE doesn't have.

PBE is cheaper at 0.59% vs 0.62% — a difference of $3.00 a year per $10,000 invested.

Over five years, FBIOX returned +3.5% a year vs +3.4% for PBE (reporting dates differ).

Updated Nov 19, 2026

FBIOX vs PBE side by side

FBIOXPBE
TypeMutual fundETF
Fund familyFidelityInvesco
CategoryTechnology SectorTechnology Sector
Expense ratio0.62%0.59%
Annual cost per $10k$62$59
10-yr cost on $10k (prospectus)$774$738
Max front load—None
12b-1 fee0%—
1-yr return+36.4%+24.7%
5-yr return (annualized)+3.5%+3.4%
10-yr return (annualized)+6.9%+5.2%
Best quarter+33.6%+25.3%
Worst quarter−28.4%−24.3%
Net assets (fund)$5.3B$281.9M
Number of holdings21533
Portfolio turnover45%103%
Returns as ofApr 30, 2026Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Year-by-year returns

YearFBIOXPBEDifference
2025+36.4%+24.7%+11.7%
2024+7.3%+1.1%+6.2%
2023+10.1%+3.7%+6.4%
2022−15.9%−10.8%−5.1%
2021−12.4%+1.6%−13.9%
2020+38.3%+25.5%+12.8%
2019+36.0%+18.3%+17.7%
2018−10.7%+0.2%−11.0%
2017+27.9%+22.4%+5.4%
2016−23.7%−23.0%−0.7%

Source: Fund prospectus bar charts

Holdings overlap

5 of FBIOX's top 25 holdings also appear in PBE's top 25.

Shared top holdings
HoldingFBIOXPBE
Amgen Inc6.53%5.22%
Gilead Sciences Inc4.82%4.43%
Alnylam Pharmaceuticals Inc2.93%3.17%
Biogen Inc1.26%4.79%
Protagonist Therapeutics Inc1.15%3.40%

Source: SEC Form N-PORT

FBIOX top 10

  1. Krystal Biotech Inc — 10.58%
  2. Abbvie Inc — 9.22%
  3. Amgen Inc — 6.53%
  4. Gilead Sciences Inc — 4.82%
  5. Fidelity Revere Street Trust — 3.35%
  6. Alnylam Pharmaceuticals Inc — 2.93%
  7. Praxis Precision Medicines Inc. — 2.47%
  8. Insmed Inc — 2.25%
  9. Argenx Se — 2.25%
  10. Ascendis Pharma A/s — 2.04%

PBE top 10

  1. Invesco Private Prime Fund — 12.89%
  2. Regeneron Pharmaceuticals, Inc. — 5.47%
  3. Amgen Inc. — 5.22%
  4. CareDx, Inc. — 5.04%
  5. Vertex Pharmaceuticals Inc. — 4.99%
  6. Invesco Private Government Fund — 4.97%
  7. Royalty Pharma PLC — 4.94%
  8. Biogen Inc. — 4.79%
  9. Gilead Sciences, Inc. — 4.43%
  10. United Therapeutics Corp. — 4.08%

FAQ

What is the difference between FBIOX and PBE?
FBIOX (Biotechnology Portfolio) and PBE (Invesco Biotechnology & Genome ETF) are both mutual funds. But FBIOX is far broader, holding 215 positions to 33 for PBE, so beyond the top names it adds exposure PBE doesn't have.
Which is cheaper, FBIOX or PBE?
PBE has the lower expense ratio (0.59%).
Should I own both FBIOX and PBE?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.